secwatch / observer
8-K filed June 2, 2026, 4:01 PM ET ticker HBIO CIK 0001123494
other confidence high sentiment neutral materiality 0.40

Stockholders approve 400,000-share increase in 2021 Incentive Plan and amendment to ESPP

HARVARD BIOSCIENCE INC

item 5.02item 5.07item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001171843-26-003877
form_type
8-K
ticker
HBIO
cik
0001123494
company_name
HARVARD BIOSCIENCE INC
filed_at
2026-06-02T20:01:17+00:00
discovered_at
2026-06-02T20:02:00.608600+00:00
generated_at
2026-06-02T20:02:12.952222+00:00
sec_items
["5.02", "5.07", "9.01"]
event_type
other
sentiment
neutral
materiality_score
0.4
calibrated_materiality_score
0.4
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001171843-26-003877
json_url
https://secwatch.observer/filing/0001171843-26-003877.json
markdown_url
https://secwatch.observer/filing/0001171843-26-003877.md
text_url
https://secwatch.observer/filing/0001171843-26-003877.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1123494/000117184326003877/0001171843-26-003877-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1123494/000117184326003877/f8k_060226.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

18191a756ad9442e92e8b1d10d9d8a0a0023c12f

HARVARD BIOSCIENCE INC shareholders approved Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan at the 2026-06-02 meeting.

Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

646754887239498f802fb15235e998235046c7e6

HARVARD BIOSCIENCE INC shareholders approved Election of two Class II Directors at the 2026-06-02 meeting.

On June 2, 2026, the Company held its Annual Meeting, at which the Company’s stockholders voted on five proposals that are described in detail in the Definitive Proxy Statement. The voting results for each of the proposals are reported below. Proposal 1 - Election of Directors The Company’s stockholders elected two Class II Directors for three-year terms, such terms to continue until the annual meeting of stockholders in 2029 and until such Directors’ successors are duly elected and qualified or until his or her earlier resignation or removal: Name Votes For Votes Withheld Broker Non-Votes John Duke 1,800,288 28,703 970,538 Katherine A. Eade 1,680,982 148,009 970,538

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

883350bf0054641d528b952b896a550b74e3741c

HARVARD BIOSCIENCE INC shareholders approved Approval, by Non-Binding Advisory Vote, of the Compensation of the Company’s Named Executive Officers at the 2026-06-02 meeting.

Proposal 3 –Approval, by Non-Binding Advisory Vote, of the Compensation of the Company’s Named Executive Officers The Company’s stockholders approved the compensation of the Company’s named executive officers by a non-binding advisory vote, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,768,695 57,111 3,185 970,538

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

93d1eab07ef3d0ad79dd5d7d3bebeaeff881e887

HARVARD BIOSCIENCE INC shareholders approved Approval of the Amended and Restated 2021 Incentive Plan at the 2026-06-02 meeting.

Proposal 5 – Approval of the Amended and Restated 2021 Incentive Plan The Company’s stockholders approved the Amended and Restated 2021 Incentive Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,131,261 680,030 17,700 970,538

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

ffc5262c3a4c3101da0e9b7e475d69fdbfe2b8fa

HARVARD BIOSCIENCE INC shareholders approved Ratification of the Appointment of Grant Thornton LLP at the 2026-06-02 meeting.

Proposal 2 –Ratification of the Appointment of Grant Thornton LLP The Company’s stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, as follows: Votes For Votes Against Votes Abstained 2,781,705 13,975 3,849

SEC 8-K Item 5.07 confidence 0.9 SEC evidence

Comparable filings

EDSA

Edesa Biotech shareholders approve equity plan amendment adding 750K shares

Edesa Biotech, Inc. May 29, 2026, 4:15 PM ET other Items 5.02, 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.02, 5.07, 9.01 same event type: other similar materiality

This filing

Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538

Comparable filing

Proposal No. 3 - Approval of Amendment to the 2019 Equity Incentive Compensation Plan The shareholders approved an amendment to the Company’s 2019 Plan to (i) increase the number of shares available for issuance thereunder plan by 750,000 shares and (ii) eliminate the annual per participant option grant limit. For Against Abstain Broker Non-Votes 2,613,551 130,589 10,680 2,147,101

Filing page SEC filing

ACIW

ACI Worldwide annual meeting approves all proposals including director elections

ACI WORLDWIDE, INC. June 2, 2026, 5:08 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538

Comparable filing

The stockholders approved, on an advisory basis, the named executive compensation as described in the 2026 Proxy Statement.

Filing page SEC filing

KYTX

Kyverna Therapeutics shareholders elect Ian Clark and Christi Shaw as Class II directors, ratify BDO USA auditor

Kyverna Therapeutics, Inc. June 2, 2026, 4:30 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538

Comparable filing

Director Nominee Votes For Votes Withheld Broker Non-Votes Ian Clark 31,505,902 3,255,231 9,225,874 Christi Shaw 34,528,865 232,268 9,225,874

Filing page SEC filing

PARK

Park Dental Partners announces shareholder voting results at 2026 annual meeting

Park Dental Partners, Inc. June 2, 2026, 4:05 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538

Comparable filing

The Company’s shareholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

Filing page SEC filing

ADCT

ADC Therapeutics shareholders approve capital range increase, equity plan expansion at 2026 AGM

ADC Therapeutics SA June 2, 2026, 4:01 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538

Comparable filing

Proposal #12 : Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company’s capital range (article 4a), conditional share capital for employee participation (article 4b) and conditional share capital for financing, acquisitions and other purposes (article 4c) as well as the introduction of article 4d regarding a conditional share capital based on the capital range The shareholders approved (i) amendments to article 4a paragraph 1 of the articles of association to increase the Company’s capital range from CHF 8,375,974.48 (lower limit) to CHF 12,354,128.80 (upper limit) to CHF 10,378,109.12 (lower limit) to CHF 15,567,163.68 (upper limit) (Proposal #12a), (ii) amendments to article 4b paragraph 1 of the articles of association to increase the Company’s conditional share capital for employee participation from 9,887,629 common shares (CHF 791,010.32) to 16,836,253 common shares (CHF 1,346,900.24) (Proposal #12b)

Filing page SEC filing

SGA

Saga Communications shareholders elect all 7 directors, approve say-on-pay and auditor ratification

SAGA COMMUNICATIONS INC June 2, 2026, 4:00 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538

Comparable filing

The seven nominees for election as directors for the ensuing year, and until their successors are elected and qualified, were elected and received the following votes:

Filing page SEC filing

XBP

XBP Global Holdings annual meeting elects directors, approves auditor and say-on-pay

XBP Global Holdings, Inc. June 1, 2026, 5:00 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538

Comparable filing

Proposal 4 — To consider and vote upon a proposal to approve, on an advisory (non-binding) basis, the frequency of future say-on-pay votes: Votes For 1 Year Votes For 2 Years Votes For 3 Years Votes Abstained Broker Non-Votes 9,200,507 333 488 332,030 577,920

Filing page SEC filing

AXON

Axon shareholders elect all 9 director nominees and approve say-on-pay at 2026 annual meeting

AXON ENTERPRISE, INC. June 1, 2026, 4:10 PM ET other Items 5.07, 9.01

same fact type: shareholder_vote same SEC item: 5.07, 9.01 same event type: other

This filing

Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538

Comparable filing

Proposal No. 2 — Advisory Vote to Approve the Compensation of the Company’s Named Executive Officers ( “ Say-on-Pay ” ) The non-binding advisory vote to approve the compensation of the Company’s named executive officers was approved as follows: FOR AGAINST ABSTAIN BROKER NON-VOTES 54,903,698 6,239,017 112,972 11,665,236

Filing page SEC filing

Source: SEC EDGAR
accession 0001171843-26-003877
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.